INHIBRX

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.

#SimilarOrganizations #People #Financial #Event #Website #More

INHIBRX

Industry:

Biotechnology Therapeutics

Founded:

2010-01-01

Address:

La Jolla, California, United States

Country:

United States

Website Url:

http://www.inhibrx.com

Total Employee:

51+

Status:

Active

Total Funding:

69.59 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Current Employees Featured

mark-lappe_image

Mark Lappe
Mark Lappe Co-Founder & CEO @ Inhibrx
Co-Founder & CEO

quinn-deveraux_image

Quinn Deveraux
Quinn Deveraux CSO & Co-Founder @ Inhibrx
CSO & Co-Founder
2018-01-01

not_available_image

Klaus W. Wagner
Klaus W. Wagner CMO @ Inhibrx
CMO

brendan-eckelman_image

Brendan Eckelman
Brendan Eckelman COO & Co-Founder @ Inhibrx
COO & Co-Founder

kelly-deck_image

Kelly Deck
Kelly Deck Chief Financial Officer @ Inhibrx
Chief Financial Officer

david-kao_image

David Kao
David Kao Vice President Regulatory Affairs @ Inhibrx
Vice President Regulatory Affairs
2021-01-01

jack-tsai_image

Jack Tsai
Jack Tsai VP Business Development @ Inhibrx
VP Business Development
2021-10-01

david-matly_image

David Matly
David Matly EVP Chief Commercial Officer @ Inhibrx
EVP Chief Commercial Officer
2021-10-01

Founder

brendan-eckelman_image

Brendan Eckelman

mark-lappe_image

Mark Lappe

quinn-deveraux_image

Quinn Deveraux

Stock Details

Company's stock symbol is NASDAQ:INBX

Investors List

ra-capital-management_image

Key Employee Changes

Date	New article
2021-10-28	Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors

Official Site Inspections

http://www.inhibrx.com Semrush global rank: 2.76 M Semrush visits lastest month: 5.86 K

Host Informations
Whois Informations

Loading ...